OTCM
GNOLF
Market cap19mUSD
Nov 24, Last price
0.01USD
Name
Genoil Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Genoil Inc., operating through its subsidiaries, specializes in the development and commercialization of advanced oil upgrading solutions. Its operations span key international markets including Canada, the Middle East, Russia, and China. At the heart of its offerings is the Genoil Hydroconversion Upgrader (GHU), a proprietary catalytic hydroconversion technology designed to transform challenging feedstocks such as high-sulfur, acidic, heavy crude oils, bitumen, and refinery residues into higher-value products with enhanced yields. Beyond oil upgrading, Genoil is also proficient in oil-water separation technologies, exemplified by its Crystal Sea Separator, an efficient tool for separating oil from water, which is supported by comprehensive engineering services. The company's portfolio further extends to specialized environmental solutions, including the Genoil Sand Decontamination Technology for purifying oil sands, as well as providing solutions for port cleaning and preventing pollution in fish farms. Other offerings encompass systems for treating bilge water, waste oil, and slop oil, alongside Allegretto-branded centrifuges. Genoil Inc. was established in 1996 and maintains its corporate headquarters in New York, New York.
Key people
Slobodan Puhalac
Vice Chairman of the Board · since 2013
David K. Lifschultz
Chairman of the Board, Chief Executive Officer, Chief Financial Officer · since 2013
Nari Narayanan
Vice President - India Operation · since 2017
Raushan Telyashev
Vice President - Genoil Middle East · since 2017
Bruce Abbott
President, Chief Operating Officer, Director · since 2013
Bengt Koch
Director · since 2013
Timothy Bojar
Independent Director · since 2012
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2020‑03 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||